- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- Finland / Suomi
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
NEW YORK, N.Y., USA: Steiner Laboratories, a leader in the field of bone regeneration, discovered the molecule necessary to regenerate the patient’s own bone. This technology eliminates the need for cadaver bone, the patient’s own harvested bone or animal bone and, more importantly, produces normal vital bone, the company asserts.
Steiner Laboratories has been awarded a patent for the first compound in the bone-graft industry that enters the osteoblast to safely stimulate osteogenesis.
(Source: Steiner Laboratories)
Thu. 18 April 2024
11:00 AM EST (New York)
Treatment approaches of advanced periodontal diseases in our daily clinical practice
Mon. 22 April 2024
10:00 AM EST (New York)
Precision in practice: Elevating clinical communication
Tue. 23 April 2024
1:00 PM EST (New York)
Growing your dental practice or DSO with better financial operations
Wed. 24 April 2024
8:00 AM EST (New York)
YITI Lounge: Navigating modern implant dentistry—from prosthetic planning to digital verification, are we there yet?
Wed. 24 April 2024
1:00 PM EST (New York)
Advanced techniques in peri-implant tissue augmentation and maintenance
Thu. 25 April 2024
12:00 PM EST (New York)
Alineadores ClearX: La evolución en el tratamiento ortodóntico con tecnología 4D
Fri. 26 April 2024
12:00 PM EST (New York)
To post a reply please login or register